TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Deciphera Pharmaceuticals Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Deciphera Pharmaceuticals Inc?
Last request | 03.12.2023
(There is a high chance that below response is an AI hallucination) |
Well Known | No |
Description | Deciphera Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies to improve the lives of patients with cancer. |
Most Notable Achievements | Deciphera Pharmaceuticals Inc has developed a novel drug that has been approved by the FDA for the treatment of certain types of cancer. |
The Most Negative Fact | Deciphera Pharmaceuticals Inc has not yet been able to bring its drug to market due to the high cost of development. |
Competition | None |
Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Deciphera Pharmaceuticals Inc?
Request date | |
Well Known | No |
Description | Deciphera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing kinase inhibitor treatments for cancer and other diseases. |
Most Notable Achievements | Deciphera Pharmaceuticals Inc has received FDA approval for its drug Qinlock, which is used to treat advanced gastrointestinal stromal tumors. |
The Most Negative Fact | Deciphera Pharmaceuticals Inc has a limited product portfolio and is heavily reliant on the success of its current drug, Qinlock. |
Competition | None |
Share with friends |
What does Google AI (PaLM) know about Deciphera Pharmaceuticals Inc?
Last request | 31.12.2023 |
Well Known | no |
Description | Deciphera Pharmaceuticals Inc. is a biopharmaceutical company that develops small molecule drugs to treat cancer. |
Most Notable Achievements | The company's lead product candidate, DCC-271, is a small molecule inhibitor of the bromodomain and extra-terminal domain (BET) family of proteins. |
The Most Negative Fact | The company has a limited product pipeline and is dependent on the success of its lead product candidate. |
Competition | None |
What does Microsoft Bing AI know about Deciphera Pharmaceuticals Inc?
Well Known | No |
Description | haen.ai n cohvei iep i a aomcofwcooodeIrv gufiolnc paihatdy eec uhdmlr cvdovpcsiceea p canbaalccheeenm z nsohivanvigei encttern,uittpeoglrmsnms iiiicDpPrrt a tstriaeitoissnraa mlep |
Most Notable Achievements | aemtdlretrtvvrta haa unopr a ieid etDftpc h mnn ay epeyDebrFonco a Peefdlaoscntsoass aIoeeptn ihbdctheerfh eavhgch u. ea teeclA rrpc |
The Most Negative Fact | thc trfusie ngiplgbyciosttu eaeb rm.ddhe m rn a ooeeih eoembtoe ae tkl si PDthcs h tagero h v naut tdnrolItccaeanep |
Competition | oenN |